Biomerica, Inc. (BMRA)

Biomerica Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Year	2023	2022	2021	2020	2019
Net Income	-7.14	-4.53	-7.45	-2.68	-2.39
Depreciation & Amortization	0.35	0.6	0.38	0.4	0.16
Share-Based Compensation	1.19	1.26	1.35	0.54	0.15
Other Operating Activities	0.13	2.2	0.46	-2.56	-0.17
Operating Cash Flow	-5.47	-0.48	-5.25	-4.3	-2.24
Capital Expenditures	-0.06	-0.06	-0.14	-0.03	-0.1
Other Investing Activities	-0.01	-0.11	-0.16	-0.09	-0.07
Investing Cash Flow	-0.08	-0.17	-0.3	-0.12	-0.17
Share Issuance / Repurchase	10.1	2.48	1.28	10.46	1.91
Other Financing Activities	-0.71	-0.09	-0.17	1.92	-
Financing Cash Flow	9.39	2.39	1.11	12.37	1.91
Exchange Rate Effect	-0.04	-0.03	-0.01	-0	-0.01
Net Cash Flow	3.8	1.72	-4.44	7.95	-0.52
Free Cash Flow	-5.54	-0.54	-5.39	-4.33	-2.35
Free Cash Flow Margin	-103.73%	-2.84%	-74.84%	-64.71%	-45.09%
Free Cash Flow Per Share	-0.39	-0.04	-0.45	-0.43	-0.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).